SQSTM1 and Parkinson disease: Specifically, we observed significant lower levels of both the autophagy substrate (p62) and autophagosome content markers (LC3BII) in PRKN-PD fibroblasts at basal and after inhibiting autophagosome fusion with lysosomes in both media.